Clinical Trial Update: Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

View source ↗

Summary

The clinical trial evaluating middle meningeal artery embolization for chronic subdural hematoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Chronic Subdural Hematoma | Status: WITHDRAWN